Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits
In conclusion, this study reveals that SFN has the ability to ameliorate HCD-induced atherosclerotic lesions progression and vascular dysfunction, possibly via its lipid-lowering and antioxidant effects and suppression of NF-B-mediated inflammation.
Source: Experimental Biology and Medicine - Category: Research Authors: Shehatou, G. S., Suddek, G. M. Tags: Pharmacology/Toxicology Source Type: research